| Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development C Dege, KH Fegan, JP Creamer, MM Berrien-Elliott, SA Luff, D Kim, ... Developmental cell 53 (2), 229-239. e7, 2020 | 78 | 2020 |
| Enabling complex genetic circuits to respond to extrinsic environmental signals A Hoynes‐O'Connor, T Shopera, K Hinman, JP Creamer, TS Moon Biotechnology and bioengineering 114 (7), 1626-1631, 2017 | 35 | 2017 |
| Identification of a retinoic acid-dependent haemogenic endothelial progenitor from human pluripotent stem cells SA Luff, JP Creamer, S Valsoni, C Dege, R Scarfò, A Dacunto, ... Nature cell biology 24 (5), 616-624, 2022 | 27 | 2022 |
| Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4 JP Creamer, C Dege, Q Ren, JTK Ho, MC Valentine, TE Druley, ... Blood, The Journal of the American Society of Hematology 129 (22), 2988-2992, 2017 | 26 | 2017 |
| Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function A Reilly, JP Creamer, S Stewart, MC Stolla, Y Wang, J Du, R Wellington, ... Cell Stem Cell 29 (4), 577-592. e8, 2022 | 22 | 2022 |
| Genetic variation in Dip5, an amino acid permease, and Pdr5, a multiple drug transporter, regulates glyphosate resistance in S. cerevisiae X Rong-Mullins, A Ravishankar, KA McNeal, ZR Lonergan, AC Biega, ... PLoS One 12 (11), e0187522, 2017 | 17 | 2017 |
| Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition M Sarchi, CA Clough, EI Crosse, J Kim, LD Baquero Galvis, N Aydinyan, ... Blood Cancer Discovery, 2024 | 3 | 2024 |
| Clonal Trajectories and Therapeutic Targeting of High-Risk SF3B1-Mutant Myelodysplastic Syndromes M Sarchi, CA Clough, A Gallì, G Todisco, JP Creamer, L Malcovati, ... Blood 140 (Supplement 1), 211-212, 2022 | 1 | 2022 |
| CD1d expression demarcates CDX4+ hemogenic mesoderm with definitive hematopoietic potential JP Creamer, SA Luff, H Yu, CM Sturgeon Stem cell research 62, 102808, 2022 | 1 | 2022 |
| Modeling Clonal Progression in SF3B1-Mutant Myelodysplastic Syndrome M Sarchi, A Gallì, CA Clough, G Todisco, JP Creamer, L Malcovati, ... Blood 138, 149, 2021 | 1 | 2021 |
| iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution M Sarchi, S Stewart, J Kim, KR Safina, S Busch, H Gizinski, N Aydinyan, ... Blood 144 (Supplement 1), 1293-1293, 2024 | | 2024 |
| Loss of 5q Drives Evolution to Aneuploidy in an iPSC Model of Complex Karyotype AML JP Creamer, S Ray, S Stewart, JS Appelbaum, M Fang, E Swisher, ... Blood 144, 629, 2024 | | 2024 |
| Mitotic Dysregulation Sensitizes Malignant Stem Cells to CHK1 Inhibition in SF3B1-Mutant Myeloid Neoplasms M Sarchi, CA Clough, EI Crosse, J Kim, LDB Galvis, A Gallì, JP Creamer, ... Blood 142, 313, 2023 | | 2023 |
| Loss of Lamin B1 in Myeloid Neoplasms with 5q Deletion Causes Myeloid-Biased Hematopoiesis and Pelger-Huet Nuclear Anomaly A Reilly, JP Creamer, MC Stolla, Y Wang, J Du, R Wellington, S Busch, ... Blood 138, 502, 2021 | | 2021 |
| 3022–GENERATION OF RETINOIC ACID-DEPENDENT HEMOGENIC ENDOTHELIAL PROGENITORS FROM HUMAN PLURIPOTENT STEM CELLS S Luff, J Creamer, C Dege, R Scarfò, S Morris, A Ditadi, C Sturgeon Experimental Hematology 88, S45, 2020 | | 2020 |
| The role of CDX4 during patterning of definitive hemogenic mesoderm JP Creamer Washington University in St. Louis, 2020 | | 2020 |
| ONTOGENY IS A CRITICAL DETERMINANT OF NATURAL KILLER CELL POTENTIAL AND FUNCTION C Sturgeon, C Dege, K Fegan, JP Creamer, M Berrien-Elliot, S Luff, D Kim, ... Experimental Hematology 76, S87, 2019 | | 2019 |
| A paper published in the journal PLOS ONE A Ravishankar, X Rong-Mullins, KA McNeal, ZR Lonergan, AC Biega, ... Effects Of Commercial Formulations Of Glyphosate On Saccharomyces Cerevisiae, 18, 2019 | | 2019 |
| Human Definitive Hematopoietic Specification from Pluripotent Stem Cells Is Regulated By Mesodermal Expression of CDX4 JP Creamer, C Dege, JTK Ho, Q Ren, MC Valentine, CM Sturgeon Blood 128 (22), 883, 2016 | | 2016 |
| Supplemental Table 3 from Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition M Sarchi, CA Clough, EI Crosse, J Kim, LDB Galvis, N Aydinyan, ... American Association for Cancer Research (AACR), 0 | | |
